Balance Sheet - MBX Biosciences, Inc. (MBX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | |
|---|---|---|---|---|
| Total cash and short-term investments | 373.71 | 262.15 | 80.68 | 42.46 |
| Accounts receivable, net | 2.12 | 0.68 | 0.21 | 0.14 |
| Other current assets | 5.71 | 4.46 | 2.58 | 1.61 |
| Total current assets | 381.54 | 267.29 | 83.47 | 44.21 |
| Total non-current assets | 3.61 | 1.25 | 0.72 | 0.88 |
| Total assets | 385.14 | 268.54 | 84.18 | 45.10 |
| Total current liabilities | 15.50 | 11.05 | 3.93 | 3.43 |
| Total non-current liabilities | 0.43 | 0.04 | 152.72 | 84.27 |
| Total liabilities | 15.92 | 11.09 | 156.65 | 87.70 |
| Total stockholders' equity | 369.22 | 257.44 | -72.47 | -42.61 |
| Common shares outstanding | 37 | 33 | 32 | 32 |
Show Quarterly Balance Sheet
Balance Sheet - MBX Biosciences, Inc. (MBX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 439.98 | 373.71 | 391.67 | 224.91 | 240.79 | 262.15 | 277.06 | 55.26 | 70.32 | 80.68 | 0.00 | 0.00 |
| Accounts receivable, net | 3.16 | 2.12 | 1.55 | 0.84 | 1.39 | 0.68 | 0.86 | 0.16 | 0.20 | 0.21 | ||
| Inventories | 0.00 | |||||||||||
| Other current assets | 5.40 | 5.71 | 4.28 | 3.44 | 2.11 | 4.46 | 3.25 | 3.38 | 2.18 | 2.58 | ||
| Total current assets | 448.54 | 381.54 | 397.50 | 229.19 | 244.28 | 267.29 | 281.17 | 58.80 | 72.70 | 83.47 | ||
| Total non-current assets | 4.17 | 3.61 | 2.57 | 2.33 | 1.65 | 1.25 | 1.23 | 4.08 | 2.62 | 0.72 | ||
| Total assets | 452.70 | 385.14 | 400.08 | 231.52 | 245.93 | 268.54 | 282.40 | 62.88 | 75.32 | 84.18 | ||
| Total current liabilities | 14.57 | 15.50 | 12.06 | 11.76 | 10.48 | 11.05 | 10.92 | 8.20 | 5.70 | 3.93 | ||
| Total non-current liabilities | 0.38 | 0.43 | 0.48 | 0.53 | 0.02 | 0.04 | 0.11 | 152.57 | 0.31 | 152.72 | ||
| Total liabilities | 14.95 | 15.92 | 12.54 | 12.28 | 10.50 | 11.09 | 11.03 | 160.77 | 6.01 | 156.65 | ||
| Total stockholders' equity | 437.76 | 369.22 | 387.54 | 219.24 | 235.42 | 257.44 | 271.37 | -97.89 | 69.31 | -72.47 | ||
| Common shares outstanding | 47 | 37 | 34 | 33 | 33 | 33 | 33 | 33 | 33 | 32 | 32 | 33 |